Feb 12 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
- BP cash bonus to be paid at 45% of target after poor performance
- Entain chief steps down after 5 months in role
- Novartis agrees $3 billion deal to buy heart drug biotech from Blackstone
- EU to retaliate against US steel and aluminium tariffs
Overview
- BP BP.L has told 39,000 employees that their annual cash bonus will be paid at just 45% of target after a year of poor financial and operational performance.
- The chief executive of Ladbrokes owner Entain ENT.L, Gavin Isaacs has stepped down after just five months in the role.
- Novartis NOVN.S has agreed to acquire Anthos Therapeutics in a deal worth up to $3.1 billion, after Blackstone Life Sciences funded the biotech's development of its treatment to help prevent strokes and other serious blood clots.
- EU said it would retaliate against U.S. tariffs on European steel and aluminium exports with "firm and proportionate countermeasures", as officials in Brussels rushed to avert a trade war with Washington.
(Compiled by Bengaluru newsroom)
((globalnewsmonitoring@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.